Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Apolipoprotein E (APOE) (N-Term) Peptide

APOE Reactivity: Human Host: Synthetic BP, IHC, WB
Catalog No. ABIN973324

Quick Overview for Apolipoprotein E (APOE) (N-Term) Peptide (ABIN973324)

Target

APOE (Apolipoprotein E (APOE))

Origin

Human

Source

  • 6
Synthetic

Application

Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
  • Protein Region

    N-Term

    Sequence

    LMDETMKELK AYKSELEEQL TPVAEETRAR LSKELQAAQA RLGADMEDVC

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-APOE Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    APOE (Apolipoprotein E (APOE))

    Background

    Chylomicron remnants and very low density lipoprotein (VLDL) remnants are rapidly removed from the circulation by receptor-mediated endocytosis in the liver. Apolipoprotein E, a main apoprotein of the chylomicron, binds to a specific receptor on liver cells and peripheral cells. ApoE is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. The APOE gene is mapped to chromosome 19 in a cluster with APOC1 and APOC2. Defects in apolipoprotein E result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants.

    Alias Symbols: AD2, LDLCQ5, LPG, MGC1571

    Protein Size: 317

    Molecular Weight

    34 kDa

    Gene ID

    348

    NCBI Accession

    NM_000041, NP_000032

    UniProt

    P02649
You are here:
Chat with us!